The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LKB1 and its importance for survival in EpCAM negative circulating tumor cells (CTC) in metastatic breast cancer.
 
Elisabeth Katharina Trapp
No Relationships to Disclose
 
Ulrich Andergassen
No Relationships to Disclose
 
Julian Gregor Koch
No Relationships to Disclose
 
Leonie Majunke
No Relationships to Disclose
 
Beate Zill
No Relationships to Disclose
 
Ayse Kurt
No Relationships to Disclose
 
Nadia Harbeck
Honoraria - Amgen; Celgene; Genomic Health; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Hexal; Novartis; Pfizer; Roche/Genentech; Sandoz
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Sven Mahner
Honoraria - AstraZeneca; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Tesaro; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Marie Lena Johanna Tzschaschel
No Relationships to Disclose
 
Thomas W. P. Friedl
No Relationships to Disclose
 
Wolfgang Janni
Employment - Eisai; GlaxoSmithKline; Novartis; Pierre Fabre; Roche; Teva
 
Brigitte Kathrin Rack
No Relationships to Disclose
 
Marianna Alunni-Fabbroni
No Relationships to Disclose